Recent evidence suggests that a lower albumin level (a recognized marker of nutritional status), when combined with lymphocyte count in a Prognostic Nutritional Index, serves as a negative prognostic factor for patients with RCC, because it is associated with tumor progression and reduced survival.33 The gene discussed is ALB; the disease is neoplasm.